Type 2 Diabetes Drug Bydureon Gets a Makeover

Roni Shye
Roni Shye, PharmD BCGP BCACP, is a licensed pharmacist in the states of Florida, Ohio, and Pennsylvania.
Posted on

The drug business is booming, especially when it comes to medications used to treat type 2 diabetes. With each passing year, drug companies are making product improvements by developing medications that are easier to take, use and store. The newest drug getting an upgrade is a once-weekly injectable Bydureon. The medication will now be available, in addition to the current Bydureon products, in an easy-to-use device known as Bydureon BCise.   

How is Bydureon BCise to be used?

The recommended dose of Bydureon BCise is 2 mg injected under the skin every 7 days (once weekly)Bydureon BCise can be given with or without food.

Bydureon will be available as a 2mg/ml single-dose autoinjector.

What are some of the main differences between the Bydureon Pen and Bydureon BCise?

The main differences between the old Bydureon Pen and the new Bydureon BCise are as follows:

Are there any serious side effects that may occur with Bydureon BCise?

Yes. Bydureon BCise, as well as all other formulations of Bydureon, have a Boxed Warning regarding the risk of thyroid tumors. A Boxed Warning is the strictest warning the FDA can give to a medication in order to warn patients and health care providers of the possible serious risks associated with a medication.

Does AstraZeneca have any cost savings programs for Bydureon BCise?

Yes. AstraZeneca is committed to supporting patient access to Bydureon BCise. Eligible commercially insured patients may pay as low as $0 for Bydureon BCise every month. Make sure to read the fine print, as cash-paying patients are limited to $150 maximum savings per 28-day supply.

For more information on Bydureon BCise, check out the manufacturer website here.

Put drug prices & coupons in your pocket!
We'll text you a link to download our free Android or iPhone app
Get GoodRx Mobile App

Filed under